Atriva Therapeutics secures 11.4MEuro federal funding.
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
You may find something interesting here, once in a while.
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
Moveshelf secured a seed investment to accelerate the digital transformation of diagnosis and care for movement disorders. Utrecht Health Seed Fund (UHSF) and Locapes Investment Fund contributed to this round.
SWORD Health Raises $25 Million in Series B to Accelerate Growth of its Best-in-Class Virtual Musculoskeletal Care Solution
Nederlandse medtech-startup Spektrax ontwikkelt met hulp van het Amsterdam UMC een test waarmee binnen een paar minuten kan worden vastgesteld of iemand besmet is met het coronavirus.
European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19.
Xsens has been acquired by Fairchild Semiconductor, a Silicon Valley industry icon that delivers power solutions for various industries including mobile, industrial, cloud and automotive. The acquisition is strategic for both companies and marks an important step for Xsens’ motion tracking success story.